Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Vanguard Emerging Markets Stock Index Fund ETF (VWO) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance

Vanguard Emerging Markets Stock Index Fund ETFTrade
Health Care Select Sector SPDR FundTrade

Price performance (Past 24H)

Key statistics

Vanguard Emerging Markets Stock Index Fund ETF vs Health Care Select Sector SPDR Fund — how do they compare? Vanguard Emerging Markets Stock Index Fund ETF trades at $60.4, while Health Care Select Sector SPDR Fund trades at $168.74. Which is the better fit depends on your goals.

VWOXLV
52-Week High
$61.24$168.44
52-Week Low
$51.20$131.16

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Vanguard Emerging Markets Stock Index Fund ETF

VWO, the Vanguard FTSE Emerging Markets ETF, trades at $60.41, up 0.13% on the day, with a bullish technical signal from moving averages and a neutral reading from oscillators. The fund's low expense ratio of 0.06% and focus on emerging markets attract institutional inflows, as seen in recent 13F filings. Recent news highlights strong capital flows into emerging market ETFs and comparisons with peers on cost and diversification.

The outlook for VWO is supported by record inflows and favorable expense ratios, but risks include concentrated exposure to developing economies and currency volatility. Analyst sentiment is generally positive due to diversification benefits and cost efficiency, though geopolitical and economic uncertainties in emerging markets pose significant headwinds for sustained growth.

Health Care Select Sector SPDR Fund

XLV, the Health Care Select Sector SPDR ETF, trades at $168.44 with a neutral daily change. Technical indicators show a bullish trend from moving averages but oscillators are neutral, with the 6-day RSI at 86.78 suggesting overbought conditions. The fund's low 0.08% expense ratio and defensive healthcare sector exposure attract steady inflows amid market volatility, as highlighted by recent ETF flow reports.

The outlook for XLV is cautiously optimistic, supported by defensive demand and strong sector earnings. Key opportunities include diversification benefits and cost efficiency, while risks involve sector-specific regulatory pressures and broader economic sensitivity. Investors should weigh the ETF's stability against potential growth limitations in a concentrated portfolio.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Vanguard Emerging Markets Stock Index Fund ETF

The fund employs an indexing investment approach designed to track the performance of the FTSE Emerging Markets All Cap China A Inclusion Index. It invests by sampling the index, meaning that it holds a broadly diversified collection of securities that, in the aggregate, approximates the index in terms of key characteristics.

Read more on VWO

About Health Care Select Sector SPDR Fund

In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.

Read more on XLV